Comprehensive Genomic Tumor Profiling

Publication Title

Illumina

Document Type

Presentation

Publication Date

12-11-2019

Keywords

genomics; oregon; portland; chiles

Abstract

NGS-based genomics assays can help characterize the genetic profile of a tumor, and these technologies are poised to supplant single-gene testing in oncology. But, what impact will this revolutionary technology have on patients, clinicians, and the entire healthcare system? Listen to Dr. Brian Piening of the Providence Cancer Institute explain how NGS is changing the standard of care in oncology.

Area of Special Interest

Cancer

Specialty/Research Institute

Earle A. Chiles Research Institute

Specialty/Research Institute

Oncology


Share

COinS